Strategic Plan: Challenges in Clinical Guideline Recommendations for Biomarker Testing in Lung Cancer
Analyze differences across published biomarker testing guidelines (timing, methodology, scope of targets) that create inconsistencies in clinical practice.
Key Activities
Updated 2026 strategic plan installment reviewing multiple organizations’ NSCLC biomarker testing guidelines and identifying inconsistencies in recommended targets, testing timing, and methodology.